Translate this page into:
Coexisting Somatostatin Receptor Expressing Gastric Neuroendocrine Tumor Primary and Lymph Nodal Tuberculosis on 68Ga-DOTANOC Positron Emission Tomography/Computed Tomography
Address for correspondence: Dr. Shamim Ahmed Shamim, Department of Nuclear Medicine, All India Institute of Medical Sciences, New Delhi, India. E-mail: sashamim2002@gmail.com
-
Received: ,
Accepted: ,
This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
This article was originally published by Wolters Kluwer - Medknow and was migrated to Scientific Scholar after the change of Publisher.
Abstract
Gastric neuroendocrine tumors (G-NETs) express somatostatin receptors (SSTR), which can be imaged using radiolabeled somatostatin analogs, including 68Ga-DOTA octreotide analogs. SSTR expression is also seen in activated lymphocytes and macrophages, which might result in false-positive results on SSTR imaging, in patients with coexistent granulomatous pathologies including tuberculosis, sarcoidosis, and Wegener's granulomatosis. We present a case where 68Ga-DOTANOC positron emission tomography/computed tomography (PET/CT) showed primary G-NET, with SSTR expressing nonregional lymph nodes which on histopathology showed necrotizing granulomas with Langhans histiocytes. Antitubercular therapy was started, and a decrease in size and SSTR expression in involved lymph nodes was noted on follow-up 68Ga-DOTANOC PET/CT.
Keywords
Gastric neuroendocrine tumors
granulomatous pathology
somatostatin receptors
tuberculosis
A 34-year-old man who presented with abdominal discomfort, decreased appetite, and weight loss on evaluation was found to have gastric polyps on endoscopy, elevated serum antiparietal cell antibody (titer 1:20), plasma chromogranin A level of 527 ng/ml (normal <76.3 ng/ml), and serum gastrin level of 977 pg/ml (13–115 pg/ml). He underwent 68Ga-DOTANOC positron emission tomography/computed tomography (PET/CT) for the evaluation of gastric neuroendocrine tumor (G-NET). The scan [Figure 1] revealed somatostatin receptor (SSTR) expressing polypoidal lesion (maximum standardized uptake value [SUVmax]: 25.7) in gastric fundus [Figure 1a-c, arrowhead] and also noted enlarged right paratracheal lymph nodes (SUVmax: 5.23) [Figure 1d-g, white arrow]. Endoscopic biopsy of gastric lesion [Figure 2a-d] shows small round cell tumor [Figure 2a], with immunohistochemistry positive for synaptophysin [Figure 2b], chromogranin [Figure 2c], and Ki-67 index <1% [Figure 2d, white arrow], suggesting well-differentiated neuroendocrine tumor (NET) (Grade 1). Histopathology of paratracheal lymph node revealed necrotizing epithelioid cell granulomatous inflammation with Langhans giant cell [Figure 2e and f, black arrows]. Considering the clinical, imaging, and node histopathology findings, the patient was started on antitubercular therapy. Follow-up 68Ga-DOTANOC PG-NET done 3 months after starting antitubercular therapy (ATT) revealed a reduction in size and SSTR expression of previously involved lymph nodes [Figure 3d-3g, white arrow] suggesting response to ATT and no significant interval change in gastric carcinoid [Figure 3a-3c, arrowhead].



G-NET is classified into four clinical types. Type 1 is most common with a lower risk of lymph nodal and distant metastases resulting in good overall prognosis.[12] Well-differentiated NET is known to express SSTR.[3] SSTR expression (68Ga-DOTANOC uptake) can also be seen in granulomatous pathologies including tuberculosis (TB), fungal, bacterial, and protozoan infections and noninfectious diseases including sarcoidosis, Crohn's disease, and Wegener's granulomatosis.[4] In chronic inflammatory pathologies, including TB, this 68Ga-DOTANOC avidity is due to the SSTR expression on activated lymphocytes and macrophages present in granulomas.[5] Although the presence of this uptake opens a window to image granulomatous pathologies as shown by Vanhagen et al., this might result in false-positive results in patients with NET having coexistent granulomatous pathologies; hence, the understanding of the false-positive sites is important for correct decision-making.[6] Sometimes, even after thorough histological examination and special stains, obvious infectious etiology resulting in granulomatous inflammation cannot be found, but Few histology features are suggestive of tuberculosis, such as granuloma formation by epithelioid histiocytes and Langhans type giant cells.[789] The diagnosis of extrapulmonary TB is sometimes difficult when bacteriological proof is lacking, but in areas with high prevalence like India (very high pretest probability), it can be assumed that granulomatous lymphadenitis is of tubercular origin after taking clinical and imaging features into consideration.[1011] Regarding the management of Type 1 G-NETs, endoscopic resection and follow-up is an acceptable treatment option.[12] In view of nonmetastatic Grade 1 gastric carcinoid in our patient, he is planned for endoscopic removal of gastric polyp and has shown good response to ATT for lymph node TB which was incidentally detected on 68Ga-DOTANOC PET/CT.
Declaration of patient consent
The authors certify that they have obtained all appropriate patient consent forms. In the form, the patient has given his consent for his images and other clinical information to be reported in the journal. The patient understands that name and initials will not be published and due efforts will be made to conceal identity, but anonymity cannot be guaranteed.
Financial support and sponsorship
Nil.
Conflicts of interest
There are no conflicts of interest.
References
- Review article: Pathogenesis and management of gastric carcinoid tumours. Aliment Pharmacol Ther. 2006;24:1305-20.
- [Google Scholar]
- Defining surgical indications for Type I gastric carcinoid tumor. Ann Surg Oncol. 2009;16:3154-60.
- [Google Scholar]
- Evaluation of positron emission tomography imaging using [68Ga]-DOTA-D Phe (1)-Tyr (3)-Octreotide in comparison to [111In]-DTPAOC SPECT. First results in patients with neuroendocrine tumors. Mol Imaging Biol. 2003;5:42-8.
- [Google Scholar]
- A clinicopathological classification of granulomatous disorders. Postgrad Med J. 2000;76:457-65.
- [Google Scholar]
- Somatostatin and the immune and haematopoetic system; A review. Eur J Clin Invest. 1994;24:91-9.
- [Google Scholar]
- Somatostatin analogue scintigraphy in granulomatous diseases. Eur J Nucl Med. 1994;21:497-502.
- [Google Scholar]
- Necrotizing granulomatous inflammation: what does it mean if your special stains are negative? Mod Pathol. 2012;25(Suppl 1):S31-8.
- [Google Scholar]
- Fine needle aspiration cytology of suspected tuberculous lymphadenitis. Cytopathology. 2002;13:284-90.
- [Google Scholar]
- Fine needle aspiration cytology. Diagnosis of tuberculosis. Diagn Cytopathol. 1987;3:6-13.
- [Google Scholar]
- Management of gastric and duodenal neuroendocrine tumors. World J Gastroenterol. 2016;22:6817-28.
- [Google Scholar]
